
It is not known whether abarelix passes into breast milk. Do not use this medication without first talking to your doctor if you are breast-feeding a baby. How should I use abarelix? Abarelix must be administered by a qualified healthcare provider. Abarelix is administered as an injection into the muscle. In some cases, the use of abarelix has resulted in serious allergic reactions. An allergic reaction may occur after any injection of the medication, including, but not limited to the first dose. Patients should be observed in the doctor's office for at least 30 minutes following each dose so that immediate treatment of an allergic reaction can be obtained if needed. Treatment with abarelix may become less effective over time in some patients. Monitoring blood levels of testosterone will be done on a regular basis with blood tests to monitor the effectiveness of the medication. It is important to use abarelix regularly to get the most benefit. Abarelix vials for injection should be stored at room temperature away from moisture and heat. What happens if I miss a dose? Contact your doctor if you miss a dose of abarelix. What happens if I overdose? An overdose of abarelix is unlikely to occur. If you do suspect that an overdose has occurred, contact your doctor, hospital emergency room, or poison control center for advice. What should I avoid while using abarelix? There are no restrictions on food, beverages, or activities while using abarelix. Follow any special instructions given by your doctor.
abatacept
antigens, cd
antigens, differentiation
immunoconjugates
antibodies, monoclonal
antigens, cd28
membrane glycoproteins
antigens, cd80
cytokines
antigens, cd86
immunosuppressive agents
cd40 ligand
interleukin 2
cd86 protein, mouse
interferon type ii
antigens, cd40
cd86 protein, human
antigens, differentiation, t lymphocyte
antigens, cd3
receptors, antigen, t cell
rna, messenger
receptors, interleukin 2
recombinant fusion proteins
ligands
tumor necrosis factor alpha
immunoglobulin g
cell adhesion molecules
interleukin 4
interleukin 10
antigens, surface
antigens, cd4
interleukin 12
recombinant proteins
receptors, immunologic
receptors, tumor necrosis factor
adjuvants, immunologic
hla dr antigens
histocompatibility antigens class ii
antigens, cd45
antibodies, blocking
intercellular adhesion molecule 1
transforming growth factor beta
adp ribosyl cyclase
antigens, neoplasm
cyclosporine
immunoglobulin fc fragments
membrane proteins
No comments:
Post a Comment